Wen X. Fan-Wenxing
Kunming, 650032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exploring the mechanisms of diethyl phthalate-induced diabetic nephropathy through integrated network toxicology, machine learning, and experimental validation.
Journal: Ecotoxicology and environmental safety
Published: September 15, 2025
A new dawn for Diabetic kidney disease: interleukin receptor antagonists.
Journal: Journal of translational medicine
Published: October 06, 2024
Analysis of research trends and hotspots in the primary treatment of end-stage renal disease.
Journal: International urology and nephrology
Published: July 11, 2024
Investigating the inflammatory mechanism of notoginsenoside R1 in Diabetic nephropathy via ITGB8 based on network pharmacology and experimental validation.
Journal: Molecular medicine (Cambridge, Mass.)
Published: June 04, 2024
Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis.
Journal: BMC endocrine disorders
Published: December 25, 2022
Relevance of the pyroptosis-related inflammasome drug targets in the Chuanxiong to improve diabetic nephropathy.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 27, 2022
Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of lncRNA expression.
Journal: Molecular immunology
Published: October 26, 2021
Efficacy of liraglutide in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
Journal: BMC endocrine disorders
Published: September 23, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026